NEVVI Medicare utilization intelligence

← back

Provider profile

GUTHRIE, JASON M.D

Rheumatology · NPI 1437299682 · SPRINGFIELD, IL

1
Groups
28
Codes · 2024
57,468
Disclosed services

GUTHRIE, JASON is a Rheumatology in SPRINGFIELD, IL, a member of 1 medical group, who billed 28 distinct codes to Medicare Part B in 2024.

Groups: SPRINGFIELD CLINIC, LLP (SPRINGFIELD, IL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

57,468
disclosed services
28
codes billed to Medicare Part B
Prior year · CY2023 88,583 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1602 Injection, golimumab, 1 mg, for intravenous use premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J1010 Injection, methylprednisolone acetate, 1 mg premiumpremium premiumpremium
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) premiumpremium premiumpremium
J1745 Injection, infliximab, excludes biosimilar, 10 mg premiumpremium premiumpremium
J2919 Injection, methylprednisolone sodium succinate, 5 mg premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
J3489 Injection, zoledronic acid, 1 mg premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
76881 Complete ultrasound scan of joint premiumpremium premiumpremium
20610 Aspiration and/or injection of fluid from large joint premiumpremium premiumpremium
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
J7050 Infusion, normal saline solution, 250 cc premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
J1030 Injection, methylprednisolone acetate, 40 mg premiumpremium premiumpremium
20604 Aspiration and/or injection of fluid from small joint using ultrasound guidance premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more premiumpremium premiumpremium
J1020 Injection, methylprednisolone acetate, 20 mg premiumpremium premiumpremium
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.